Ledger.Open graph →
SEC Form D · Amendment · filed July 14, 2023

Cardurion Pharmaceuticals, Inc

Offering
$128.1M
Sold
$128.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BURLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Michael Mendelsohn · Burlington, MAExec · DirectorNicholas Downing · Burlington, MADirectorKenneth Novack · Burlington, MADirectorPeter Lawrence · Burlington, MAExec · DirectorJeb Keiper · Burlington, MADirectorKeith Gottesdiener · Burlington, MADirectorAdam Koppel · Burlington, MADirectorChris Bakker · Calgary, Alberta, CanadaExec · DirectorBrad Paterson · Calgary, Alberta, CanadaDirectorSandeep Kini · Edmonds, WAExec · DirectorGreg Bronson · Calgary, Alberta, CanadaDirectorRyan Agresta · Edmonds, WADirectorAustin Watkins · Edmonds, WADirectorMichael Leo · Calgary, Alberta, CanadaDirectorMelissa Lee · Ottawa, OHDirectorNemanja Kostic · San Francisco, CADirectorChristopher Golda · San Francisco, CAExec · DirectorMark H. Longenecker · Chicago, ILDirectorJonathan Berent · Mountain View, CADirectorJohn Kuelper · Mountain View, CAExec · DirectorJulie O'Hara · Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗